Startseite Medizin Metabolic disorders in vertically HIV-infected children: future adults at risk for cardiovascular disease
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Metabolic disorders in vertically HIV-infected children: future adults at risk for cardiovascular disease

  • Marta Dapena , Beatriz Jiménez , Antoni Noguera-Julian , Pere Soler-Palacín EMAIL logo , Clàudia Fortuny , Rebeca Lahoz , Francisco Javier Aracil , Concepción Figueras und María Isabel de José
Veröffentlicht/Copyright: 19. April 2012

Abstract

Background: Despite metabolic disorders in HIV-infected children being widely described, there is still a lack of agreed criteria for diagnoses and management. Numerous studies are coming from other settings and results are heterogeneous when assessing several analytical and clinical parameters.

Objectives: To describe the prevalence of metabolic disorders and associated risk factors in the Spanish National cohort of HIV-infected pediatric patients (CoRISpe).

Methods: This was a cross-sectional study following all vertically HIV-infected children and adolescents in three referral centers included in the CoRISpe. Metabolic data (fasting lipids, glucose and insulin levels and thyroid hormone levels) were collected. Fat distribution was clinically assessed by expert clinicians.

Results: We included 157 patients [median age 13 years, interquartile range (IQR) 10–16]. Median duration of antiretroviral therapy was 10.2 years (IQR 5.0–13.0). Almost 20% of patients had insulin resistance and this was associated with hepatitis C co-infection, current use of stavudine (d4T) and hypertriglyceridemia. Hypercholesterolemia and hypertriglyceridemia were found in 23.9% and 24.8% of patients and were associated with current use of protease inhibitors (p=0.042 and p=0.022, respectively). Abnormal fat distribution was observed in 63 patients (40.5%): lipoatrophy in 32 (20.4%), lipohypertrophy in eight (5.1%) and a mixed pattern in 23 patients (14.6%), and it was significantly associated with previous exposure to stavudine (p<0.001).

Conclusions: Metabolic disorders are a significant problem in our HIV-infected pediatric population. We need to encourage the development of global strategies and the creation of consensus guidelines that can decrease the cardiovascular risk in this population.


Corresponding author: Dr. Pere Soler-Palacín, Pediatric Infectious Diseases and Immunodeficiencies Unit Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona Passeig de la Vall d’Hebron, 119-129 08035, Barcelona, Spain Phone: +34 934893140, Fax: +34 934893039

Received: 2012-1-8
Accepted: 2012-3-1
Published Online: 2012-04-19
Published in Print: 2012-06-01

©2012 by Walter de Gruyter Berlin Boston

Artikel in diesem Heft

  1. Masthead
  2. Masthead
  3. Reviews
  4. Growth failure in children with cystic fibrosis
  5. Approach to the management of slipped capital femoral epiphysis and primary hyperparathyroidism
  6. Original Articles
  7. Thyroid developmental anomalies among first-degree relatives of children with thyroid dysgenesis and congenital hypothyroidism
  8. TSHR is the main causative locus in autosomal recessively inherited thyroid dysgenesis
  9. When to operate on ovarian cysts in children?
  10. Partial anomalous pulmonary venous return is common in Turner syndrome
  11. Uterine development in patients with Turner syndrome: Relation to hormone replacement therapy and karyotype
  12. Ovarian and uterine ultrasonography and relation to puberty in healthy girls between 6 and 16 years in the Turkish population: a cross-sectional study
  13. Assessment of gonadal function in boys and adolescents at the diagnosis of neoplastic disease
  14. Environmental and genetic factors influence age at menarche in women with polycystic ovary syndrome
  15. Vitamin D status in children with Hashimoto thyroiditis
  16. Non-invasive measurement of adrenal response after standardized exercise tests in prepubertal children
  17. Bone metabolism biomarkers, body weight, and bone age in healthy Brazilian male adolescents
  18. Safety and efficacy of a 1-year treatment with zoledronic acid compared with pamidronate in children with osteogenesis imperfecta
  19. Evaluation and comparison of safety, convenience and cost of administering intravenous pamidronate infusions to children in the home and ambulatory care settings
  20. Clinical profile and etiologies of children with central diabetes insipidus: a single-center experience from Turkey
  21. Audiologic evaluation in pediatric patients with type 1 diabetes mellitus
  22. An after-school dance and lifestyle education program reduces risk factors for heart disease and diabetes in elementary school children
  23. Evaluation of neutrophil gelatinase-associated lipocalin in normoalbuminuric normotensive type 1 diabetic adolescents
  24. The association of serum lipocalin-2 levels with metabolic and clinical parameters in obese children: a pilot study
  25. Metabolic disorders in vertically HIV-infected children: future adults at risk for cardiovascular disease
  26. Ghrelin and growth hormone secretagogue receptor (GHSR) genes are not commonly involved in growth or weight abnormalities in an Israeli pediatric population
  27. Patient Reports
  28. Splenogonadal fusion and sex reversal
  29. The earlier described mutation (c.307C>T [p.R103X]) in the SRD5A2 gene causing a 46,XY female phenotype
  30. Sertoli cell tumor and intratubular germ cell neoplasia located in separate gonads in an adolescent patient with complete androgen insensitivity: a case report and review of literature
  31. Seizure due to somatostatin analog discontinuation in a case diagnosed as congenital hyperinsulinism novel mutation
  32. Simultaneous onset and similar course of type 1 diabetes mellitus in monozygotic twins (a 4-year follow-up)
  33. 17β-Hydroxysteroid dehydrogenase type 3 deficiency as a result of a homozygous 7 base pair deletion in 17βHSD3 gene
  34. Clinical and image-guided chorioretinal findings in long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency
  35. Influence of HLA DQ 2/8 genotypes in predisposing type 1 diabetes in siblings of a Saudi family with paternally inherited chromosomal translocations
  36. An unusual association between growth hormone deficiency and a middle cranial fossa arachnoid cyst
  37. Type 2 diabetes mellitus in a young girl: ominous presentation and atypical course
  38. Marked increase of final height by long-term aromatase inhibition in a boy with idiopathic short stature
  39. A case of Rabson-Mendenhall syndrome with a novel mutation in the tyrosine kinase domain of the insulin receptor gene complicated by medullary sponge kidney
  40. Persistent hyperinsulinemic hypoglycemia of infancy
  41. Septo-optic dysplasia and hemophagocytic lymphohistiocytosis in an infant
  42. Primary familial hypomagnesemia syndrome: a new approach in treatment
  43. A case of congenital hypothyroidism in PHACE syndrome
  44. Short Communication
  45. Is vitamin D deficiency a feature of pediatric celiac disease?
  46. Letters to the Editor
  47. Authors’ reply to “The appropriate use of sensitive tests of hypothalamic-pituitary-adrenal axis suppression”
  48. Diagnosis of non-alcoholic fatty liver disease in obese children
  49. Meetings
  50. Meetings Calendar
Heruntergeladen am 19.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2012-0005/pdf
Button zum nach oben scrollen